Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luciana A. Costa is active.

Publication


Featured researches published by Luciana A. Costa.


Diabetic Medicine | 2004

Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes.

Luciana A. Costa; Luis Henrique Santos Canani; Hugo Roberto Kurtz Lisboa; Glaucia Sarturi Tres; Jorge Luiz Gross

Aims  To investigate the association of features of the metabolic syndrome with the prevalence of chronic complications.


Revista Da Associacao Medica Brasileira | 2004

Prevalência de complicações micro e macrovasculares e de seus fatores de risco em pacientes com diabetes melito do tipo 2 em atendimento ambulatorial

Rafael Selbach Scheffel; Desirê Bortolanza; Cristiane Seganfredo Weber; Luciana A. Costa; Luis Henrique Santos Canani; Kátia Gonçalves dos Santos; Daisy Crispim; Israel Roisenberg; Hugo Roberto Kurtz Lisboa; Glaucia Sarturi Tres; Balduíno Tschiedel; Jorge Luiz Gross

BACKGROUND: Type 2 diabetes (DM2) has been related to the development of macroangiopatic [coronary heart disease (CHD), peripheral vascular disease (PVD) and stroke] and microangiopatic [retinopathy, nephropathy, and distal sensory neuropathy (DSN)] complications. The aims of this study were to analyze prevalence of complications in DM2 patients and to estimate their associated risk factors. METHODS: Cross-sectional study, including 927 out patients with DM2 from three medical centers in Rio Grande do Sul: Hospital de Clinicas de Porto Alegre (n = 475), Grupo Hospitalar Conceicao (n = 229) and Hospital Sao Vicente de Paula (n = 223). Of the patients 42% were male, mean age was 59 ± 10 years and the median known duration of DM2 was 11 (5 - 43) years. Retinopathy was identified by direct fundoscopy; CHD by WHO questionnaire and/or abnormal ECG and/or perfusion abnormalities on myocardial scintigraphy; DSN by compatible symptoms and absent sensation on 10 g monofilament and/or tune fork; PVD by the presence of claudication and absent foot pulses; stroke by presence of sequels and history; and nephropathy by the urinary albumin excretion rate (>20 µg/min). Hypertension was defined by blood pressure (>140/90 mmHg) and/or use of antihypertensive drugs. Body mass index (BMI, kg/m2) and waist-to-hip ratio (WHR) were calculated. RESULTS: CHD was present in 36% and PVD in 33% of the patients. Among the microvascular, 37% had nephropathy (12% with macroalbuminuria); 48% retinopathy (15% proliferative retinopathy). DSN was present in 36%. Seventy three percent of the patients presented arterial hypertension. Cholesterol levels were >200 mg/dl in 64% and BMI > 30 kg/m2 in 36%. Twenty two percent of patients were smokers and 21% ex-smokers. CONCLUSION: Diabetic complications are frequent among out patients referring to general hospitals. Almost all patients presented at least one risk factor for cardiovascular disease, justifying the efforts for identification and adequate control.


Brazilian Journal of Medical and Biological Research | 2006

Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes.

M.C. Boelter; Jorge Luiz Gross; Luis Henrique Santos Canani; Luciana A. Costa; H.R. Lisboa; Glaucia Sarturi Tres; Jacó Lavinsky; Mirela Jobim de Azevedo

Diabetic retinopathy is one of the leading causes of blindness in working-age individuals. Diabetic patients with proteinuria or those on dialysis usually present severe forms of diabetic retinopathy, but the association of diabetic retinopathy with early stages of diabetic nephropathy has not been entirely established. A cross-sectional study was conducted on 1214 type 2 diabetic patients to determine whether microalbuminuria is associated with proliferative diabetic retinopathy in these patients. Patients were evaluated by direct and indirect ophthalmoscopy and grouped according to the presence or absence of proliferative diabetic retinopathy. The agreement of diabetic retinopathy classification performed by ophthalmoscopy and by stereoscopic color fundus photographs was 95.1% (kappa = 0.735; P < 0.001). Demographic information, smoking history, anthropometric and blood pressure measurements, glycemic and lipid profile, and urinary albumin were evaluated. On multiple regression analysis, diabetic nephropathy (OR = 5.18, 95% CI = 2.91-9.22, P < 0.001), insulin use (OR = 2.52, 95% CI = 1.47-4.31, P = 0.001) and diabetes duration (OR = 1.04, 95% CI = 1.01-1.07, P = 0.011) were positively associated with proliferative diabetic retinopathy, and body mass index (OR = 0.90, 95% CI = 0.86-0.96, P < 0.001) was negatively associated with it. When patients with macroalbuminuria and on dialysis were excluded, microalbuminuria (OR = 3.3, 95% CI = 1.56-6.98, P = 0.002) remained associated with proliferative diabetic retinopathy. Therefore, type 2 diabetic patients with proliferative diabetic retinopathy more often presented renal involvement, including urinary albumin excretion within the microalbuminuria range. Therefore, all patients with proliferative diabetic retinopathy should undergo an evaluation of renal function including urinary albumin measurements.


Diabetic Medicine | 2005

The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes

Luis Henrique Santos Canani; Luciana A. Costa; Daisy Crispim; K. Gonçalves dos Santos; Israel Roisenberg; Hugo Roberto Kurtz Lisboa; G. Sarturi Tres; Ana Luiza Maia; Jorge Luiz Gross

Aim  To investigate the association between angiotensin‐converting enzyme gene I/D polymorphism and diabetic nephropathy (DN) in patients with Type 2 diabetes mellitus (DM) taking into consideration the known duration of DM.


Diabetes | 2003

The Human Peroxisome Proliferator-Activated Receptor γ2 (PPARγ2) Pro12Ala Polymorphism Is Associated With Decreased Risk of Diabetic Nephropathy in Patients With Type 2 Diabetes

Maria Luiza Caramori; Luis Henrique Santos Canani; Luciana A. Costa; Jorge Luiz Gross


Diabetes Care | 2002

The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients.

Luciana A. Costa; Luis Henrique Santos Canani; Ana Luiza Maia; Jorge Luiz Gross


Diabetes Research and Clinical Practice | 2006

A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients

Luciana A. Costa; Jorge de Faria Maraschin; José X. Castro; Jorge Luiz Gross; Rogério Friedman


Archive | 2003

Avaliação das complicações crônicas relacionadas ao diabete melito

Jorge Luiz Gross; Sandra Pinho Silveiro; Mirela Jobim de Azevedo; Themis Zelmanovitz; Maria Cristina Boelter; Luciana A. Costa


Archive | 2003

Terapia com aspirina ainda é subtilizada entre pacientes com diabetes melito do tipo 2

Rafael Selbach Scheffel; Ana Luiza Krahe; Fernanda Stringari; Luciana A. Costa; Miriam Pecis; Lérida Zlavasky


Archive | 2002

Agregação dos componentes da Síndrome Metabólica aumenta a proporção das complicações do diabete em pacientes com diabete melito tipo 2

Desirê Bortolanza; Rafael Selbach Scheffel; Cristiane Seganfredo Weber; Luciana A. Costa; Luis Henrique Santos Canani; Jorge Luiz Gross

Collaboration


Dive into the Luciana A. Costa's collaboration.

Top Co-Authors

Avatar

Jorge Luiz Gross

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Luis Henrique Santos Canani

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Ana Luiza Maia

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jorge de Faria Maraschin

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Rafael Selbach Scheffel

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Daisy Crispim

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Israel Roisenberg

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

José X. Castro

Universidade Federal do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge